BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 20564384)

  • 1. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies.
    Zhao L; Feng SS
    J Pharm Sci; 2010 Aug; 99(8):3552-60. PubMed ID: 20564384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation.
    Win KY; Feng SS
    Biomaterials; 2006 Apr; 27(10):2285-91. PubMed ID: 16313953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
    Mu L; Feng SS
    J Control Release; 2003 Jan; 86(1):33-48. PubMed ID: 12490371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
    Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
    Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).
    Mu L; Feng SS
    J Control Release; 2002 Apr; 80(1-3):129-44. PubMed ID: 11943393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
    Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
    Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembled nanoparticles of poly(lactide)--Vitamin E TPGS copolymers for oral chemotherapy.
    Zhang Z; Feng SS
    Int J Pharm; 2006 Nov; 324(2):191-8. PubMed ID: 16842944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
    Feng SS; Mu L; Win KY; Huang G
    Curr Med Chem; 2004 Feb; 11(4):413-24. PubMed ID: 14965222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
    Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
    Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel.
    Xie J; Wang CH
    Pharm Res; 2005 Dec; 22(12):2079-90. PubMed ID: 16132339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles.
    Pan J; Feng SS
    Biomaterials; 2008 Jun; 29(17):2663-72. PubMed ID: 18396333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
    Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
    Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments.
    Turk CT; Oz UC; Serim TM; Hascicek C
    AAPS PharmSciTech; 2014 Feb; 15(1):161-76. PubMed ID: 24222270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.
    Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS
    Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
    Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
    Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.